Newly diagnosed Crohn's disease patients show imbalance in intestinal microbial population

March 12, 2014

A multi-institutional study led by investigators from Massachusetts General Hospital (MGH) and the Broad Institute has identified how the intestinal microbial population of newly diagnosed Crohn's disease patients differs from that of individuals free of inflammatory bowel disease (IBD). In their paper in the March 12 issue of Cell Host and Microbe, the researchers report that Crohn's patients showed increased levels of harmful bacteria and reduced levels of the beneficial bacteria usually found in a healthy gastrointestinal tract.

Several studies have suggested that the excessive immune response that characterizes Crohn's may be associated with an imbalance in the normal microbial population, but the exact relationship has not been clear. The current study analyzes data from the RISK Stratification Study, which was designed to investigate microbial, genetic and other factors in a group of children newly diagnosed with Crohn's disease or other inflammatory bowel diseases. At 28 participating centers in the U.S. and Canada, samples of intestinal tissues were taken from 447 participants with a clear diagnosis of Crohn's and 221 control participants with noninflammatory gastrointestinal conditions. The researchers also analyzed samples from an additional group of about 800 participants in previous studies, for a total of more than 1,500 individuals.

Advanced sequencing of the microbiome – the genome of the entire microbial population – in tissue samples taken from sites at the beginning and the end of the large intestine revealed a significant decrease in diversity in the of the Crohn's patients, who had yet to receive any treatment for their disease. The samples revealed an abnormal increase in the proportion of inflammatory organisms in Crohn's patients and a drop in noninflammatory and beneficial species, compared with the . The imbalance was even greater in patients whose symptoms were more severe and those who had markers of inflammatory activity in tissue samples.

"These results identifying the association of specific bacterial groups with Crohn's disease provide opportunities to mine the Crohn's-disease-associated microbiome to develop diagnostics and therapeutic leads," said senior author Ramnik Xavier, MD, PhD, chief of the MGH Gastrointestinal Unit and director of the MGH Center for the Study of Inflammatory Bowel Disease.

Other key findings of the study include: identifying the niches of specific microbial strains in Crohn's disease and their effects on other microbial community members; finding that rectal biopsies can indicate the presence of disease early in the course of Crohn's, regardless of which intestinal segments are affected; showing that fecal samples collected at onset of disease do not reflect changes in the bacterial communities of the intestinal lining.

Antibiotics are often prescribed for symptoms suggestive of Crohn's before a diagnosis is made, but in participants who happened to be taking antibiotics at the time samples were taken, the microbial imbalance was even more pronounced, suggesting that the antibiotic use could actually exacerbate symptoms rather than relieve them, the authors note. Next steps will be to uncover the function of these microbes and their products and to learn how the microbiome and microbial products interact with the patient's immune system, with the possibility that these interactions could represent the molecular basis for the disease.

"Identifying which are key to disease onset and to inflammation resolution in and establishing which can be effectively targeted are our best hope to uncover the first microbiome-based therapies in IBD, says Xavier, who is the Isselbacher Professor of Medicine in Gastroenterology at Harvard Medical School.

Explore further: Scientists discover the specific types of macrophages that affect Crohn's disease severity

More information: Cell Host & Microbe, Gevers et al.: "The treatment-naive microbiome in new onset Crohn's Disease." dx.doi.org/10.1016/j.chom.2014.02.005

Related Stories

Scientists discover the specific types of macrophages that affect Crohn's disease severity

February 28, 2014
For those coping with Crohn's disease, a new research report published in the Journal of Leukocyte Biology offers hope for the development of new and more effective drugs. In the report, scientists show for the first time, ...

Specific bacterial species may initiate, maintain Crohn's

October 22, 2012
Patients newly diagnosed with pediatric Crohn's disease had significantly different levels of certain types of bacteria in their intestinal tracts than age-matched controls, according to a paper in the October Journal of ...

New research finds that enzyme is absent in Crohn's disease sufferers

September 18, 2013
Royal Veterinary College researcher Dr David Bishop-Bailey, alongside collaborators from University College London, Queen Mary University London, the University of Umeå and the National Institute of Environmental Health ...

Biologic agents provide relief for children newly diagnosed with Crohn's disease

February 3, 2014
Children newly diagnosed with Crohn's disease may benefit from early treatment with the biologic drugs known as anti-TNF-α agents, according to a new study in Gastroenterology1, the official journal of the American Gastroenterological ...

'Pouchitis' after ulcerative colitis surgery linked to changes in gene expression

October 10, 2013
"Pouchitis" developing after surgery for ulcerative colitis (UC) is associated with changes in gene expression, which increase along with disease severity, reports a study in Inflammatory Bowel Diseases, official journal ...

Specialized intestinal cells cause some cases of Crohn's disease

October 2, 2013
Scientists have discovered that Crohn's disease, the inflammatory bowel disorder, can originate from specialised intestinal cell type called Paneth cells. As such, they propose that small intestinal Crohn's disease might ...

Recommended for you

Co-infection with two common gut pathogens worsens malnutrition in mice

July 27, 2017
Two gut pathogens commonly found in malnourished children combine to worsen malnutrition and impair growth in laboratory mice, according to new research published in PLOS Pathogens.

Finish your antibiotics course? Maybe not, experts say

July 27, 2017
British disease experts on Thursday suggested doing away with the "incorrect" advice to always finish a course of antibiotics, saying the approach was fuelling the spread of drug resistance.

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

July 26, 2017
A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for giant cell arteritis, the ...

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.